Error: Could not add to watchlist. X

Carnegie Fund II - Biotechnology Sub-Fund

+ Watchlist
CARBIOA:LX
37.96
EUR
As of 00:00:00 ET on 07/03/2015.
Volume
0
52Wk Range
23.96 - 39.58
1 Yr Return
59.97%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/03/2015)
37.96
Total Assets (m EUR) (on 06/30/2015)
34.683
Inception Date
10/10/2000
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
ULF ARVIDSSON
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.10%
Expense Ratio
1.10%
Top Fund Holdings
Name Position Value % of Fund
Biogen Inc 8.20 k 2.99 m 8.29
Gilead Sciences Inc 29.00 k 2.98 m 8.24
Celgene Corp 27.00 k 2.84 m 7.85
Vertex Pharmaceuticals Inc 23.90 k 2.76 m 7.65
BioMarin Pharmaceutical Inc 15.00 k 1.72 m 4.75
Medivation Inc 13.80 k 1.66 m 4.59
Mylan NV 24.00 k 1.60 m 4.44
Regeneron Pharmaceuticals Inc 3.35 k 1.57 m 4.36
Cempra Inc 43.00 k 1.41 m 3.92
Isis Pharmaceuticals Inc 22.10 k 1.36 m 3.78
Profile
Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.
ADDRESS
c/o Carnergie Fund Services SA
P.O. BOX 1141
L-1011 Luxembourg
Luxembourg
PHONE
352-40-40-30-1